[Effect of oxyphenbutazone on immunologic reactions. 2. Passive cutaneous anaphylaxis (PCA) treated with oxyphenbutazone, cortisone and cyclophosphamide].
D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D003348:Cortisone / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology*; D004890:Erythema; D005260:Female; D006168:Guinea Pigs; D007106:Immune Sera / Q000008:administration & dosage; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007271:Injections, Intradermal; D008297:Male; D010113:Oxyphenbutazone / Q000494:pharmacology*; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects*; D011817:Rabbits; D012709:Serum Albumin / Q000008:administration & dosage
D007106:Immune Sera; D007166:Immunosuppressive Agents; D012709:Serum Albumin; D003520:Cyclophosphamide; D010113:Oxyphenbutazone; D003348:Cortisone
Die Beeinflussung immunologischer Reaktionen durch Oxyphenbutazon. 2. Die passive cutane Anaphylaxie (PCA) unter der Behandlung mi Oxyphenbutazon, Cortison und Cyclophosphammid.